References

  1. Government of India. Revised National TB Control Programme, Status Report. 2009. Central TB Division, Government of India, DGHS. Government of India. PubMed | Google Scholar

  2. World Health Organization. Global tuberculosis report 201 201 Geneva. World Health Organization. Google Scholar

  3. World Health Organization. WHO Tuberculosis Programme: framework for effective tuberculosis control. 1994. Geneva. World Health Organisation. Google Scholar

  4. Verver S, Warren RM, Beyers N, Richardson M, Van Der Spuy GD et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005; 171(12):1430-5. PubMed | Google Scholar

  5. Ottmani SE, Zignol M, Bencheikh N, Laâsri L, Chaouki N, Mahjour J. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis. 2006 Dec;10(12):1367-72. PubMed | Google Scholar

  6. Dooley KE, Lahlou O, Ghali I, Knudsen J, Elmessaoudi MD, Cherkaoui I, El Aouad R. Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Public Health. 2011 Feb; 11:140. PubMed | Google Scholar

  7. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2007; (4):CD003343. PubMed | Google Scholar

  8. Vree M, Huong NT, Duong BD, Sy ON, Van le N, Co NV, Cobelens FGJ, Borgdorff MW. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study. BMC Public Health. 2007; 7:134. PubMed | Google Scholar

  9. Kolappan C, Subramani R, Karunakaran K, Narayanan PR. Mortality of tuberculosis patients in Chennai, India. WHO Bulletin. 2006 ; 84 (7) : 555-560. PubMed | Google Scholar

  10. Maartens G, Wilkinson RJ. Tuberculosis. Lancet. 2007;370:2030e43. PubMed | Google Scholar

  11. Thomas C. A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy. J Manag Med. 2002; 16:371-400. PubMed | Google Scholar

  12. Estifanos Biru S, Bernt L. Determinants of Treatment Adherence among Smear-Positive Pulmonary Tuberculosis patients in Southern Ethiopia. PLoS Medicine. 2007; 4(2): e37. PubMed | Google Scholar

  13. Pefura Yone EW, Kengne AP, Kuaban C. Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study. BMJ. 2011; 1. PubMed | Google Scholar

  14. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 1993. Geneva, Switzerland. WHO. PubMed | Google Scholar

  15. TB Unit of the WHO Regional Office for Eastern-Mediterranean Region. WHO Country profile 2008-2009: Morocco. 2008. Geneva. TB Unit of the WHO Regional Office for Eastern-Mediterranean Region. PubMed | Google Scholar

  16. Sanou A, Dembele M, Theobald S, Macq J. Access and adhering to tuberculosis treatment: Barriers faced by patients and communities in Burkina Faso. Int J Tuberc Lung Dis. 2004; 8(12): 1479-1483. PubMed | Google Scholar

  17. Jaiswal A, Singh V, Ogden JA, Porter JD, Sharma PP, et al. Adherence to tuberculosis treatment: Lessons from the urban setting of Delhi, India. Trop Med Int Health. 2003;8(7): 625-633. PubMed | Google Scholar

  18. McNagny SE, Ahluwalia JS, Clark WS, Resnicow KA. Cigarette smoking and severe uncontrolled hypertension in inner-city African Americans. Am J Med. 1997; 103(2):121-7. PubMed | Google Scholar

  19. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of non adherence to hypertension treatment in an inner-city minority population. Am J Public Health 1992, 82(12):1607-12. Google Scholar

  20. Migliori GB, Hopewell PC, Blasi F et al. Improving the TB case management: The International Standards for Tuberculosis care. Eur Respir J. 2006; 28:687-90. PubMed | Google Scholar

  21. Ait-Khaled N, Alarco´n E, Armengol R, et al. Prise en charge de la tuberculose :guide des éléments essentiels pour une bonne pratique. 2010. Paris. Union Internationale Contre la Tuberculose et les Maladies Respiratorires. PubMed | Google Scholar

  22. World Health Organization. 2008. http://www.emro.who.int/stb/pdf/CountryProfile-mor-08.pdf. Accessed in 2008.

  23. Kaona FA, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004; 4: 68. PubMed | Google Scholar

  24. Ifebunandu NA, Ukwaja KN. Tuberculosis treatment default in a large tertiary care hospital in urban Nigeria: prevalence, trend, timing and predictors. J Infect Public Health. 2012; 5(5):340-5. PubMed | Google Scholar

  25. World Health Organization. 2005 Report, Global tuberculosis control: Surveillance planning, financing. 2005. Geneva. World Health Organization. PubMed | Google Scholar

  26. Muture BN, Keraka M, Kimuu PK, Kabiru E, Ombeka VO, Oguya F. Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya: A case control study. BMC Public Health. 2011, 11:696. PubMed | Google Scholar

  27. Demissie M, Kabede D.Defaulting from tuberculosis treatment at the Addis Ababa TB Centre and factors associated with it. Ethiopian Medical Journal. 1994; 32(2):97-106. PubMed | Google Scholar

  28. Balbay O, Annakkaya AN, Arbak P, Bilgin C, Erbas M. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Dis. 2005 Jun; 58(3):152-8. PubMed | Google Scholar

  29. Bashour H, Mamaree F. Gender differences and tuberculosis in the Syrian Arab Republic: patients? attitudes, compliance and outcomes. East Mediterr Health J. 2003 Jul; 9(4):757-68. PubMed | Google Scholar

  30. O'Boyle SJ, Power JJ, Ibrahim MY, Watson JP. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis. 2002; 6(4):307-12. PubMed | Google Scholar

  31. Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007; 11(8):828-837. PubMed | Google Scholar

  32. Hasker E, Khodjikhanov M, Usarova S, Asamidinov U, Yuldashova U, van der Werf MJ, Uzakova G, Veen J. Default from tuberculosis treatment in Tashkent, Uzbekistan; who are these defaulters and why do they default? BMC Infect Dis. 2008; 8:97. Google Scholar

  33. Kliiman K, Altraja A. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2010 Apr; 14(4):454-63. PubMed | Google Scholar

  34. Park J, Nachman S. The link between religion and HAART adherence in pediatric HIV patients. AIDS Care. 2010 May; 22(5):556-61. PubMed | Google Scholar

  35. Kisenyi RN, Muliira JK, Ayebare E. Religiosity and Adherence to Antiretroviral Therapy Among Patients Attending a Public Hospital-Based HIV/AIDS Clinic in Uganda. J Relig Health. 2013 Mar; 52(1):307-17. PubMed | Google Scholar

  36. Tachfouti N, Berraho M, Elfakir S, Serhier Z, El Rhazi K, Slama K, Nejjari C. Socioeconomic status and tobacco expenditures among Moroccans: Results of the MARTA survey. American Journal of Health Promotion. 2010; 24(5):334-9. PubMed | Google Scholar

  37. Burton NT, Forson A, Lurie MN, Kudzawu S, Kwarteng E, Kwara A. Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana. Trans R Soc Trop Med Hyg. 2011; 105(12):675-82. PubMed | Google Scholar

  38. E. Elbireer S, Guwatudde D, Mudiope P, Nabbuye-Sekandi J, Manabe YC. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda. Tropical Medicine and International Health. 2011; 16: 981-987. PubMed | Google Scholar